Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia ...

Shingrix is a onetime vaccination, given in two doses a few months apart. The CDC recommends it starting at age 50 for most ...

A groundbreaking new study suggests a potential cure for slowing cognitive decline has been right under our noses.

Getting vaccinated against shingles may not only lower risk for the condition — it may offer some protection against dementia ...

New research has linked the shingles vaccine to a reduced risk of dementia, but who is eligible for the jab and what are the ...

The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a weakened immune system (for example, if you have recently been treated for ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Shingles are more common than people think but there is help in the form of a vaccination. SHINGRIX is an FDA-approved vaccine for the prevention of shingles in adults 50 years ...

Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.

Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...